Andrey P.
- Country
- Bulgaria
- Department
- Clinical Pharmacology
Research Overview
- Bioequivalence Study of Cladribine 10 mg in Healthy Volunteers for Potential Use in Highly Active Relapsing Multiple Sclerosis
- Evaluation of Safety, Tolerability, and Pharmacokinetics of ALY688ER in Overweight or Obese Adults with Nonalcoholic Steatohepatitis (NASH)
- Bioequivalence Study of Cladribine 10 mg Tablets Versus Mavenclad 10 mg Tablets in Healthy Adults Under Fed Conditions
Data & Insights
Has run more than one trial at 3 of 7 partner sites.
Specializations
Multiple Sclerosis and Neuroinflammatory Disease
Andrey Petrov is involved in clinical research on relapsing multiple sclerosis, progressive multiple sclerosis, and related central nervous system inflammation, with attention to therapies that target relapse control, disability progression, and neuroaxonal injury.
- Relapsing forms of multiple sclerosis
- Nonrelapsing secondary progressive multiple sclerosis
- Serum neurofilament and MRI-based CNS inflammation
His work also extends to broader autoimmune neurology, including chronic inflammatory demyelinating polyneuropathy and upper limb spasticity after stroke or traumatic brain injury.
Inflammatory Bowel Disease and Gastrointestinal Immunology
His clinical trial activity includes Crohn’s disease, ulcerative colitis, and other forms of inflammatory bowel disease, focusing on therapies aimed at controlling intestinal inflammation and improving symptomatic disease activity.
- Crohn’s disease
- Ulcerative colitis
- Moderately to severely active inflammatory bowel disease
This area also reflects interest in immune-mediated mucosal disease and treatment options for persistent gastrointestinal inflammation.
Respiratory Disease and Allergic Airway Disorders
Andrey Petrov contributes to studies in asthma, chronic obstructive pulmonary disease, bronchiectasis, and idiopathic pulmonary fibrosis, with emphasis on airway control, exacerbation reduction, and inflammatory respiratory phenotypes.
- Severe asthma
- Chronic obstructive pulmonary disease
- Allergic rhinitis and house dust mite allergy
His research landscape also includes respiratory allergy and type 2 inflammation across chronic airway disease.
Cardiometabolic Risk and Blood Pressure Disorders
His trial portfolio covers atherosclerotic cardiovascular disease, hyperlipidemia, hypertriglyceridemia, heart failure, and difficult-to-control hypertension, with interest in therapies that reduce cardiovascular risk and improve hemodynamic control.
- Atherosclerotic cardiovascular disease
- Heart failure with reduced or preserved ejection fraction
- Resistant hypertension and uncontrolled hypertension
He is also active in research on atrial fibrillation, high cardiovascular risk, and obesity-related cardiometabolic disease.
Autoimmune, Allergic, and Rare Inflammatory Disorders
Andrey Petrov is involved in studies of systemic lupus erythematosus, lupus nephritis, systemic sclerosis, Sjögren’s syndrome, psoriatic arthritis, and hereditary angioedema, reflecting a strong therapeutic focus on immune dysregulation and rare disease management.
- Hereditary angioedema and chronic spontaneous urticaria
- Systemic lupus erythematosus and lupus nephritis
- Sjögren’s syndrome and systemic sclerosis
His research also includes migraine, idiopathic inflammatory myopathies, and other immune-mediated diseases.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.